Alicia J. Jenkins - Concepedia

Author

Alicia J. Jenkins

Also Known As

A J JENKINS, A J Jenkins, A JENKINS, A Jenkins, A. J. JENKINS, A. J. Jenkins, A. Jenkins, A.J. Jenkins, AJ Jenkins, ALICIA J JENKINS

662

Publications

22.3K

Citations

H-Index

181

Concepts

All Affiliations

The University of Melbourne The University of Sydney National Health and Medical Research Council St Vincent's Hospital Melbourne Medical University of South Carolina

About

Alicia J. Jenkins is an author at The University of Melbourne specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	80	5.3K
2	Health Sciences	14	15	1.5K
3	Engineering	2	2	47
4	Natural Sciences	1	1	36
5	Nursing	1	1	13

Alicia J. Jenkins

260

Publications

15.4K

Citations

H-Index

Page 1

	Year	Citations
The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions Min-Xin Fu, Jesús R. Requena, Alicia J. Jenkins, Journal of Biological Chemistry	1996	793
Effects of Insulin Resistance and Type 2 Diabetes on Lipoprotein Subclass Particle Size and Concentration Determined by Nuclear Magnetic Resonance W. Timothy Garvey, Soon-Ho Kwon, Deyi Zheng, Diabetes Insulin Resistance SyndromeHyperlipidemiaInsulin SignalingObesityMetabolic Syndrome	2003	602
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial John R. Petrie, Nish Chaturvedi, Ian Ford, The Lancet Diabetes & Endocrinology Metabolic SyndromeType 1Diabetes ManagementCardiovascular DiseaseDiabetes	2017	337
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial Gary Wittert, Karen Bracken, Kristy Robledo, The Lancet Diabetes & Endocrinology Metabolic SyndromeDiabetes ManagementAndrologyUrologyDiabetes	2020	334
Diabetic Retinopathy and Serum Lipoprotein Subclasses in the DCCT/EDIC Cohort Timothy J. Lyons, Alicia J. Jenkins, Deyi Zheng, Investigative Ophthalmology & Visual Science	2004	307
Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein Jesús R. Requena, Min Fu, Mahtab U. Ahmed, Biochemical Journal	1997	292
Pyridoxamine, an Inhibitor of Advanced Glycation Reactions, Also Inhibits Advanced Lipoxidation Reactions Joelle M. Onorato, Alicia J. Jenkins, Suzanne R. Thorpe, Journal of Biological Chemistry	2000	246
Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort Zhuo Chen, Miao Feng, Andrew D. Paterson, Proceedings of the National Academy of Sciences	2016	238
Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance With Dyslipidemia Youlian Liao, Soon-Ho Kwon, Sara Shaughnessy, Diabetes Care	2004	216
Lipoproteins in the DCCT/EDIC cohort: Associations with diabetic nephropathy Alicia J. Jenkins, Timothy J. Lyons, Deyi Zheng, Kidney International Metabolic SyndromeDcct/edic CohortDiabetes EpidemiologyMedicineDiabetes	2003	211

Page 1